For the quarter ended June 2025, The Beauty Health Company (SKIN) reported revenue of $78.2 million, down 13.7% over the same period last year. EPS came in at $0.03, compared to -$0.10 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $74.55 million, representing a surprise of +4.89%. The company delivered an EPS surprise of +150%, with the consensus EPS estimate being -$0.06.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Beauty Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenue- Americas: $52 million versus the two-analyst average estimate of $51.35 million. The reported number represents a year-over-year change of -9.9%.
- Geographic Revenue- EMEA: $18.4 million versus $16.23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.2% change.
- Geographic Revenue- Asia Pacific: $7.7 million compared to the $5.63 million average estimate based on two analysts. The reported number represents a change of -43.4% year over year.
- Delivery Systems Net Sales: $22.4 million versus $19.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -36.4% change.
- Consumables Net Sales: $55.8 million versus the two-analyst average estimate of $55.34 million. The reported number represents a year-over-year change of +0.7%.
View all Key Company Metrics for Beauty Health here>>>
Shares of Beauty Health have returned -23.9% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Beauty Health Company (SKIN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
